An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13

被引:144
作者
Bowen, DJ [1 ]
机构
[1] Univ Wales Coll Cardiff, Coll Med, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales
关键词
ABO blood-group system; blood proteins; endopeptidases; von Willebrand disease; von Willebrand factor;
D O I
10.1046/j.1538-7836.2003.00007.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The susceptibility of von Willebrand factor (VWF) of blood group O, A. B and AB to proteolysis by the ADAMTS13 metalloprotease was investigated. Multimeric analysis indicated that the rate of VWF proteolysis differed between blood groups and was greater for group O VWF than for non-O VWF in the rank order O greater than or equal to B > A greater than or equal to AB. Measurement of the collagen binding activity of VWF of each blood group following proteolysis for a fixed time interval corroborated the results obtained on multimer analysis: the loss of collagen binding activity was greater for VWF of group O compared with non-O VWF, in the rank order O greater than or equal to B > A greater than or equal to AB. Ristocetin was found to increase the rate of VWF proteolysis approximately two-fold the differential between blood groups was retained in the presence of ristocetin.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 28 条
[1]   INTERACTION OF THE VON-WILLEBRAND-FACTOR (VWF) WITH COLLAGEN - LOCALIZATION OF THE PRIMARY COLLAGEN-BINDING SITE BY ANALYSIS OF RECOMBINANT VWF A DOMAIN POLYPEPTIDES [J].
CRUZ, MA ;
YUAN, HB ;
LEE, JR ;
WISE, RJ ;
HANDIN, RI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10822-10827
[2]   STRUCTURE DETERMINATION OF THE MAJOR ASPARAGINE-LINKED SUGAR CHAIN OF HUMAN FACTOR-VIII - VONWILLEBRAND-FACTOR [J].
DEBEIRE, P ;
MONTREUIL, J ;
SAMOR, B ;
MAZURIER, C ;
GOUDEMAND, M ;
VANHALBEEK, H ;
VLIEGENTHART, JFG .
FEBS LETTERS, 1983, 151 (01) :22-26
[3]   CARBOHYDRATE MOIETY OF VON WILLEBRAND FACTOR IS NOT NECESSARY FOR MAINTAINING MULTIMERIC STRUCTURE AND RISTOCETIN COFACTOR ACTIVITY BUT PROTECTS FROM PROTEOLYTIC DEGRADATION [J].
FEDERICI, AB ;
ELDER, JH ;
DEMARCO, L ;
RUGGERI, ZM ;
ZIMMERMAN, TS .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2049-2055
[4]   von Willebrand factor: Measuring its antigen or function? Correlation between the level of antigen, activity, and multimer size using various detection systems [J].
Fischer, BE ;
Thomas, KB ;
Dorner, F .
THROMBOSIS RESEARCH, 1998, 91 (01) :39-43
[5]   TRIPLET STRUCTURE OF VON-WILLEBRAND-FACTOR REFLECTS PROTEOLYTIC DEGRADATION OF HIGH-MOLECULAR-WEIGHT MULTIMERS [J].
FURLAN, M ;
ROBLES, R ;
AFFOLTER, D ;
MEYER, D ;
BAILLOD, P ;
LAMMLE, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7503-7507
[6]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234
[7]  
Gerritsen HE, 1999, THROMB HAEMOSTASIS, V82, P1386
[8]  
GILL JC, 1987, BLOOD, V69, P1691
[9]   O-linked protein glycosylation structure and function [J].
Hounsell, EF ;
Davies, MJ ;
Renouf, DV .
GLYCOCONJUGATE JOURNAL, 1996, 13 (01) :19-26
[10]  
HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362